BROADWOOD CAPITAL INC — 13F Holdings & Portfolio
CIK 1278387 · latest 13F-HR filed 2026-08-14
BROADWOOD CAPITAL INC manages $1.91B in 13F-reported U.S. long-equity assets across 6 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are MNST (40.73%), STAA (24.18%), AXON (20.32%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions and exited 0; 5 existing positions rose in reported value and 1 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-14
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
| Name | Title / Status | Ownership | Type |
|---|
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- MONSTER BEVERAGE CORP NEW$191.8M +32.7%
- STAAR SURGICAL CO$161.1M +53.4%
- AXON ENTERPRISE INC$94.3M +32.0%
- INSIGHT MOLECULAR DIA INC$35.7M +91.2%
- ISHARES TR$24.9M +21.1%
BROADWOOD CAPITAL INC Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | MONSTER BEVERAGE CORP NEW | MNST | 61174X109 | $779.3M | 40.73% | 8,107,796 | SH |
| 2 | STAAR SURGICAL CO | STAA | 852312305 | $462.6M | 24.18% | 16,123,842 | SH |
| 3 | AXON ENTERPRISE INC | AXON | 05464C101 | $388.8M | 20.32% | 693,504 | SH |
| 4 | ISHARES TR | IWM | 464287655 | $142.7M | 7.46% | 474,920 | SH |
| 5 | INSIGHT MOLECULAR DIA INC | IMDX | 68235C206 | $74.8M | 3.91% | 12,684,884 | SH |
| 6 | LINEAGE CELL THERAPEUTICS IN | LCTX | 53566P109 | $64.9M | 3.39% | 49,560,992 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $1.91B | 6 | 0000919574-26-005163 |
| 2026-03-31 | 2026-05-15 | $1.42B | 6 | 0000919574-26-003144 |
| 2025-12-31 | 2026-02-17 | $1.70B | 12 | 0000919574-26-001013 |
| 2025-09-30 | 2025-11-14 | $1.66B | 12 | 0000919574-25-006810 |
3RD FLOOR
NEW YORK, NY 10019